Vitamin D Treatment and Hypogonadism in Men
NCT01748370 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2018-03-20
Summary
Low total testosterone (TT) is present in about 30% of men aged \>60 years and in up to 7% of younger men. Male hypogonadism is associated with metabolic and cardiovascular diseases as well as with increased mortality. There is evidence showing a relationship of TT with vitamin D in men. We aim at evaluating the effect of vitamin D supplementation on TT and metabolic parameters in hypogonadal men. We will study the effects of 20,000 IU vitamin D weekly in a 12 wk randomized, double-blind, placebo-controlled trial in 100 men with TT \<3.0 ng/ml and 25-hydroxyvitamin D (25(OH)D) \<30 ng/ml (patients) as well as in 100 men with TT ≥3.0 ng/ml and 25(OH)D \<30 ng/ml (controls). Vitamin D supplementation might be a safe therapeutic approach improving TT levels as well as metabolic parameters in hypogonadal men. Further the effects of vitamin D on androgens will be evaluated in eugonadal men.
Conditions
- Hypogonadism
Interventions
- DRUG
-
Vitamin D supplementation in hypogonadal men
- DRUG
-
Vitamin D supplementation in eugonadal men
- DRUG
-
Placebo hypogonadal
- DRUG
-
Placebo eugonadal
Sponsors & Collaborators
-
Medical University of Graz
lead OTHER
Principal Investigators
-
Elisabeth Lerchbaum, MD · Medical University of Graz
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-12-01
- Primary Completion
- 2017-11-12
- Completion
- 2017-11-12
Countries
- Austria
Study Locations
More Related Trials
-
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.
NCT00104572 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly
NCT00117000 ·Status: UNKNOWN ·Phase: PHASE3
-
Testosterone Replacement in Older Men and Atherosclerosis Progression
NCT00287586 ·Status: COMPLETED ·Phase: PHASE4
-
The Testosterone Trials in Older Men
NCT00799617 ·Status: COMPLETED ·Phase: PHASE3
-
Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease
NCT01578473 ·Status: COMPLETED ·Phase: PHASE1
-
Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial
NCT00260390 ·Status: UNKNOWN ·Phase: PHASE4
-
Testosterone Replacement in Men With Diabetes and Obesity
NCT01127659 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
NCT01084369 ·Status: TERMINATED ·Phase: PHASE4
-
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
NCT03887936 ·Status: COMPLETED ·Phase: PHASE4
-
Hypogonadism in Young Men With Type 2 Diabetes
NCT01155518 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Testosterone Replacement on Insulin Resistance
NCT00487734 ·Status: COMPLETED ·Phase: PHASE4
-
Reandron in Diabetic Men Witn Low Testosterone Level
NCT00613782 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Trial of Testosterone Undecanoate
NCT01765179 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Determine the Effects of Testosterone Replacement Therapy in Aging Men With Androgen Deficiency
NCT00161304 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men
NCT00695110 ·Status: COMPLETED ·Phase: PHASE2
-
Does Testosterone Improve Function in Hypogonadal Older Men
NCT00304213 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy
NCT01816295 ·Status: COMPLETED ·Phase: PHASE3
-
Testosterone Treatment for Hypogonadal Men
NCT00433199 ·Status: COMPLETED ·Phase: PHASE3
-
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
NCT06312761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism
NCT00962637 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Testosterone Supplementation on Rehabilitation Outcomes
NCT00037999 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Testosterone Lotion in the Treatment of Hypogonadal Males
NCT00372008 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)
NCT03118479 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients
NCT00847314 ·Status: COMPLETED
-
Testosterone Replacement in Diabetes With Vascular Disease (Version 2)
NCT00355537 ·Status: COMPLETED ·Phase: PHASE4